Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKCA | P17252 | 6/20 | 0.57 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.48 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.43 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.43 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.43 |
| ▸ | AR | P10275 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL77521 | 0.98 | PRKCA (0.59) | PRKCATDP1PRKCEPRKCQPRKCD | |
| SCHEMBL7758874 | 0.98 | PRKCA (0.59) | PRKCATDP1PRKCEPRKCQPRKCD | |
| SCHEMBL7759898 | 0.98 | PRKCA (0.59) | PRKCATDP1PRKCEPRKCQPRKCD | |
| Triacetin SCHEMBL9802800 | 0.94 | PRKCA (0.57) | PRKCATDP1PRKCEPRKCQPRKCD | |
| Acetic Acid SCHEMBL8675242 | 0.94 | PRKCA (0.56) | PRKCATDP1PRKCEPRKCQPRKCD | |
| Ethylene Glycol SCHEMBL16612582 | 0.94 | PRKCA (0.56) | PRKCATDP1PRKCEPRKCQPRKCD | |
| Isopropyl Alcohol SCHEMBL11286605 | 0.92 | PRKCA (0.54) | PRKCATDP1 | |
| Triacetin SCHEMBL821340 | 0.91 | TDP1 (0.56) | PRKCATDP1AR | |
| Triacetin SCHEMBL3870 | 0.91 | TDP1 (0.56) | PRKCATDP1AR | |
| SCHEMBL11876020 | 0.90 | PRKCA (0.49) | PRKCATDP1PRKCEPRKCQPRKCD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11446231-B2 | Oral care compositions and methods for the same | COLGATE-PALMOLIVE COMPANY (US) | 2022-09-20 | — | — | US | claimed |
| EP-3883541-A1 | ORAL CARE COMPOSITIONS COMPRISING A POLYVINYL CAPRALACTAM-POLYVINYL ACETATE-POLYETHYLENE GLYCOL GRAFT COPOLYMER, AND METHODS FOR THE SAME | Colgate-Palmolive Company (US) | 2021-09-29 | — | — | EP | claimed |
| US-20200206123-A1 | Oral Care Compositions and Methods for the Same | COLGATE-PALMOLIVE COMPANY (US) | 2020-07-02 | — | — | US | claimed |
| WO-2020139597-A1 | ORAL CARE COMPOSITIONS COMPRISING A POLYVINYL CAPRALACTAM-POLYVINYL ACETATE-POLYETHYLENE GLYCOL GRAFT COPOLYMER, AND METHODS FOR THE SAME | COLGATE-PALMOLIVE COMPANY (US) | 2020-07-02 | — | — | WO | claimed |
| US-11446231-B2 | Oral care compositions and methods for the same | COLGATE-PALMOLIVE COMPANY (US) | 2022-09-20 | — | — | US | disclosed |
| EP-3883541-A1 | ORAL CARE COMPOSITIONS COMPRISING A POLYVINYL CAPRALACTAM-POLYVINYL ACETATE-POLYETHYLENE GLYCOL GRAFT COPOLYMER, AND METHODS FOR THE SAME | Colgate-Palmolive Company (US) | 2021-09-29 | — | — | EP | disclosed |
| US-20200206123-A1 | Oral Care Compositions and Methods for the Same | COLGATE-PALMOLIVE COMPANY (US) | 2020-07-02 | — | — | US | disclosed |
| WO-2020139597-A1 | ORAL CARE COMPOSITIONS COMPRISING A POLYVINYL CAPRALACTAM-POLYVINYL ACETATE-POLYETHYLENE GLYCOL GRAFT COPOLYMER, AND METHODS FOR THE SAME | COLGATE-PALMOLIVE COMPANY (US) | 2020-07-02 | — | — | WO | disclosed |
| CN-108602759-A | The method for preparing the composition of alkanolamine alkylamide and polyalcohol | 阿克苏诺贝尔化学品国际有限公司 | 2018-09-28 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200206123-A1 | Oral Care Compositions and Methods for the Same | RPN1, PSMC2, KRTCAP2 | PRKCA 2538/4885TDP1 2561/4885PRKCE 1496/4885 |
| US-11446231-B2 | Oral care compositions and methods for the same | RPN1, PSMC2, KRTCAP2 | PRKCA 2538/4885TDP1 2561/4885PRKCE 1496/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.